Notch signaling pathway in ovarian cancer

Stephen L Rose1

  • 1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Wisconsin School of Medicine and Public Health, Madison, WI 53792, USA. srose2@wisc.edu

Insights

Notch signaling plays a complex role in cancer, acting as both an oncogene and tumor suppressor. This review explores Notch

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Ovarian cancer remains a leading cause of cancer-related deaths in women globally.
  • Current treatments like chemotherapy and surgery have limitations, necessitating novel therapeutic strategies.
  • Notch signaling is implicated in various cancers, exhibiting context-dependent oncogenic or tumor-suppressive functions.

Purpose of the Study:

  • To review the current understanding of Notch signaling in ovarian cancer.
  • To investigate the evidence for Notch pathway activation in ovarian cancer.
  • To explore potential therapeutic strategies targeting Notch inactivation for ovarian cancer treatment.

Main Methods:

  • Literature review of existing studies on Notch signaling and ovarian cancer.
  • Analysis of evidence for Notch pathway involvement in ovarian cancer pathogenesis.
  • Identification of potential therapeutic targets within the Notch signaling pathway.

Main Results:

  • The review highlights the dual role of Notch signaling in cancer, influencing tumor development and progression.
  • Evidence suggests Notch pathway activation in a significant proportion of ovarian cancer cases.
  • Specific Notch pathway components are identified as potential targets for therapeutic intervention.

Conclusions:

  • Notch signaling is a critical player in ovarian cancer, with its activation correlating with disease progression.
  • Targeting Notch inactivation presents a promising avenue for developing novel ovarian cancer therapies.
  • Further research is warranted to elucidate the precise mechanisms and optimize therapeutic strategies.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...